BOSTON SCIENTIFIC DL-,01
stock DE:BSX (FRANKFURT)

Alternative ID: US1011371077

Watch List

  • Exchange: FRANKFURT
  • Sector: Healthcare
  • Industry: Medical Devices
  • Market Cap: Large (62.15B)
  • Data in EUR
  • EPS: 0.68
  • Current PE: 70.51
  • BVPS: 10.17
  • Price/BVPS: 4.73
  • Hist Grade: C (61.64)
  • YOY Grade: E (32.34)
  • Debt/FCF: 6.68
  • ROIC: 4.0%
  • PEG: 1.18
  • PEGY: 1.18
  • Value Price: 25.75
  • MOS Price: 12.88
  • MOS %: -46.4%
  • Graham Number: 12.47
  • Graham MOS %: -74.1%
  • IRT: 16.36

Market Price

48.07 

-0.77 -1.6%

as of Mar 22 '23

52 Week Range:

33.48 49.22

Stock Analyzer Tutorials

S2O Stock Analyzer - General Info

General Info


type: video (mp4); length: 3:30

Demonstrates how to use Stock Analyzer, shows how to analyze a stock and explains in detail "General Info" section of the Stock Analyzer result page.

S2O Stock Analyzer - Financial Statements

Financial Statements


type: video (mp4); length: 5:10

Explains information presented in the Financial Statements section of the S2O Stock Analyzer: financial statements charts, absolute values and growth rates.

S2O Stock Analyzer - Growth Grade and Financial Ratios

Growth Grade and Financial Ratios


type: video (mp4); length: 5:09

Demonstrates how to use Growth Grade & Financial Ratios section; shows the difference between historical and year-over-year Growth Grade on the real life example.

S2O Stock Analyzer - Value Price

Value Price


type: video (mp4); length: 6:03

Demonstrates how to use Value Price (intrinsic value) and the Graham Number, MOS (margin of safety) and IRT - Investment Recovery Time; explains 3 different projection models used to compute value price - pessimistic, moderate and optimistic.

S2O Stock Analyzer - Price Charts

Price Charts


type: video (mp4); length: 8:34

Demonstrates basic rules of how to read a candlestick chart, long and short term moving averages, stochastic, MACD and relative strength (RS) charts. Explains how bull or bear market condition is computed.

General Info

  • Exchange: FRANKFURT
  • Sector: Healthcare
  • Industry: Medical Devices
  • Market Cap: Large (62.15B)
  • Inst. Ownership: 93.47%
  • Insider Ownership: 0.24%
  • Full Time Employees: 41000
Boston Scientific Corporation develops, manufactures, and markets medical devices for use in various interventional medical specialties worldwide. It operates through three segments: MedSurg, Rhythm and Neuro, and Cardiovascular. The company offers devices to diagnose and treat gastrointestinal and pulmonary conditions; devices to treat various urological and pelvic conditions; implantable cardioverter and implantable cardiac resynchronization therapy defibrillators; pacemakers and implantable cardiac resynchronization therapy pacemakers; and remote patient management systems. It also provides medical technologies to diagnose and treat rate and rhythm disorders of the heart comprising 3-D cardiac mapping and navigation solutions, ablation catheters, diagnostic catheters, mapping catheters, intracardiac ultrasound catheters, delivery sheaths, and other accessories; spinal cord stimulator systems for the management of chronic pain; indirect decompression systems; and deep brain stimulation systems. In addition, the company offers interventional cardiology products, including drug-eluting coronary stent systems used in the treatment of coronary artery disease; percutaneous coronary interventions products to treat atherosclerosis; intravascular catheter-directed ultrasound imaging catheters, fractional flow reserve devices, and systems for use in coronary arteries and heart chambers, as well as various peripheral vessels; and structural heart therapies. Further, it provides stents, balloon catheters, wires, and atherectomy systems to treat arterial diseases; thrombectomy and acoustic pulse thrombolysis systems, wires, and stents to treat venous diseases; and peripheral embolization devices, radioactive microspheres, ablation systems, cryotherapy ablation systems, and micro and drainage catheters to treat cancer. The company was incorporated in 1979 and is headquartered in Marlborough, Massachusetts.

Financial Statements

The charts below show selected Annual and Quarterly Financial Data.

The purpose of these charts is to discover long and short term change dynamics. When numbers are growing year after year in the annual statements chart, the business become stronger and stronger and this is a good sign.

Quarterly Data Chart can be used to do a short term analysis. It makes sense to pay attention to the quarterly dynamics and do not wait for the next yearly statement. We should be alerted if we see that quarterly numbers are going down.

You can check "Annual Financial Statements" and "Quarterly Financial Statements" sections for exact numbers and growth rates.

Annual Statements

On a charts below the Line shows absolute values and the Bar chart shows Year-Over-Year Growth Rate for selected financial statement item. A consistent GROWTH is generally considered necessary to fund future growth from within a business.
NOTE: Growth Rate is not provided if either the latest period or the year-ago period contains a net loss. (source: WSJ Digest of Earnings)
TIP! move your mouse pointer over bar or a circle on any chart below to see details.

Financial Statements

Income Statement


 

Cash Flow Statement


 

Balance Sheet


 

Liquidity Ratios

Current Ratio

 

Current Ratio measures the ability to meet short term obligations. Generally accepted standard is 2 (current assets should be 2 times or 200% of current liabilities).

Quick Ratio

 

Measures immediate liquidity or the cash available to cover immediate liabilities. A safe margin would be at least 1 (100%).

Financial Leverage

 

Defined as total assets divided by total shareholders' equity. The higher the ratio, the more debt a company uses in its capital structure.

Profitability Ratios

ROA

 

Return on Assets (ROA) measures the income (profit) that is generated by the use of the assets of the business.

ROE

 

Return on Equity (ROE) is a measure of profitability that calculates how many dollars of profit a company generates with each dollar of shareholders equity. ROE is sometimes called "return on net worth."

ROIC

 

The Return on Invested Capital (ROIC) measure gives a sense of how well a company is using its money to generate returns. Some investors use this figure as a final evaluation to determine whether or not to invest in a company.

Annual Statements

Item Name Dec '11 Dec '12 Dec '13 Dec '14 Dec '15 Dec '16 Dec '17 Dec '18 Dec '19 Dec '20 Dec '21
Equity (BVPS) 6.14
3.80
3.61
4.15
4.36
4.50
4.63
5.24
6.22
8.97
10.17
growth rate -38.1% -5.0% 15.0% 5.1% 3.2% 2.9% 13.2% 18.7% 44.2% 13.4%
Earnings BIT 499.48
-3,197.58
-173.49
959.00
1,083.00
1,391.00
1,599.00
1,724.00
1,831.00
1,129.00
2,009.00
growth rate -100.0% 0.0% 100.0% 12.9% 28.4% 15.0% 7.8% 6.2% -38.3% 78.0%
Avg.PE 18.21
-1.20
27.62
27.62
27.62
94.62
286.58
77.18
77.18
77.18
77.18
growth rate -100.0% 100.0% 0.0% 0.0% 242.6% 202.9% -73.1% 0.0% 0.0% 0.0%
ROA 2.03
-21.16
-0.72
-0.71
-1.36
1.92
0.56
8.35
18.23
-0.37
3.13
growth rate -100.0% 0.0% 0.0% 0.0% 100.0% -70.8% 1,391.1% 118.3% -100.0% 100.0%
ROE 3.89
-44.65
-1.80
-1.83
-3.74
5.32
1.51
21.24
41.59
-0.79
6.17
growth rate -100.0% 0.0% 0.0% 0.0% 100.0% -71.6% 1,306.6% 95.8% -100.0% 100.0%
ROIC 3.92
-28.53
0.78
0.17
-0.63
4.00
1.92
13.02
25.17
0.95
5.15
growth rate -100.0% 100.0% -78.2% -100.0% 100.0% -52.0% 578.1% 93.3% -96.2% 442.1%
Cur. Ratio 1.72
1.71
1.65
1.26
1.43
0.90
0.68
0.76
0.97
1.82
1.47
growth rate -0.6% -3.5% -23.6% 13.5% -37.1% -24.4% 11.8% 27.6% 87.6% -19.2%
Quick Ratio 0.84
0.80
0.84
0.62
0.66
0.47
0.30
0.33
0.44
0.89
0.87
growth rate -4.8% 5.0% -26.2% 6.5% -28.8% -36.2% 10.0% 33.3% 102.3% -2.3%
Leverage 1.88
2.50
2.53
2.64
2.87
2.69
2.72
2.41
2.20
2.01
1.94
growth rate 33.0% 1.2% 4.4% 8.7% -6.3% 1.1% -11.4% -8.7% -8.6% -3.5%
Balance Sheet Dec '11 Dec '12 Dec '13 Dec '14 Dec '15 Dec '16 Dec '17 Dec '18 Dec '19 Dec '20 Dec '21
Acct.Receivable 969.39
946.83
1,016.85
1,183.00
1,275.00
1,472.00
1,548.00
1,645.00
1,828.00
1,531.00
1,778.00
growth rate -2.3% 7.4% 16.3% 7.8% 15.5% 5.2% 6.3% 11.1% -16.3% 16.1%
Acct.Payable 262.00
209.00
447.00
530.00
349.00
542.00
513.00
794.00
growth rate -20.2% 113.9% 18.6% -34.2% 55.3% -5.4% 54.8%
Cur.Assets 2,415.69
2,351.12
2,342.56
3,606.00
3,471.00
3,239.00
3,822.00
4,002.00
4,699.00
6,694.00
6,317.00
growth rate -2.7% -0.4% 53.9% -3.7% -6.7% 18.0% 4.7% 17.4% 42.5% -5.6%
Total Assets 16,563.62
13,345.81
12,892.24
17,024.00
18,133.00
18,096.00
19,042.00
20,999.00
30,565.00
30,777.00
32,229.00
growth rate -19.4% -3.4% 32.1% 6.5% -0.2% 5.2% 10.3% 45.6% 0.7% 4.7%
Cash 207.73
161.05
168.83
587.00
319.00
196.00
188.00
146.00
217.00
1,734.00
1,925.00
growth rate -22.5% 4.8% 247.7% -45.7% -38.6% -4.1% -22.3% 48.6% 699.1% 11.0%
Inventory 724.32
687.75
697.87
946.00
1,016.00
955.00
1,078.00
1,166.00
1,579.00
1,351.00
1,610.00
growth rate -5.1% 1.5% 35.6% 7.4% -6.0% 12.9% 8.2% 35.4% -14.4% 19.2%
Cur.Liabilities 1,405.85
1,378.62
1,419.07
2,846.00
2,430.00
3,587.00
5,654.00
5,260.00
4,866.00
3,681.00
4,274.00
growth rate -1.9% 2.9% 100.6% -14.6% 47.6% 57.6% -7.0% -7.5% -24.4% 16.1%
Liabilities 7,730.99
8,000.95
7,804.90
10,567.00
11,813.00
11,363.00
12,030.00
12,273.00
16,688.00
15,451.00
15,607.00
growth rate 3.5% -2.5% 35.4% 11.8% -3.8% 5.9% 2.0% 36.0% -7.4% 1.0%
LT Debt 3,311.95
3,308.06
3,296.39
3,841.00
5,674.00
5,419.00
3,814.00
4,797.00
8,586.00
9,123.00
8,798.00
growth rate -0.1% -0.4% 16.5% 47.7% -4.5% -29.6% 25.8% 79.0% 6.3% -3.6%
Equity 8,832.63
5,344.86
5,087.34
6,457.00
6,320.00
6,733.00
7,012.00
8,726.00
13,877.00
15,326.00
16,622.00
growth rate -39.5% -4.8% 26.9% -2.1% 6.5% 4.1% 24.4% 59.0% 10.4% 8.5%
Common Shares 1,519.00
1,407.00
1,341.00
1,324.00
1,341.00
1,377.00
1,393.00
16.00
16.00
17.00
17.00
growth rate -7.4% -4.7% -1.3% 1.3% 2.7% 1.2% -98.9% 0.0% 6.3% 0.0%
Cash Flow Statement Dec '11 Dec '12 Dec '13 Dec '14 Dec '15 Dec '16 Dec '17 Dec '18 Dec '19 Dec '20 Dec '21
Capital Expenditures 224.06
163.38
149.38
259.00
247.00
376.00
319.00
316.00
461.00
376.00
554.00
growth rate -27.1% -8.6% 73.4% -4.6% 52.2% -15.2% -0.9% 45.9% -18.4% 47.3%
Cash Dividends 0.00
0.00
28.00
28.00
28.00
28.00
55.00
growth rate 0.0% 0.0% 0.0% 96.4%
Cash From OA 784.22
980.28
841.80
1,269.00
691.00
1,182.00
1,426.00
310.00
1,836.00
1,508.00
1,870.00
growth rate 25.0% -14.1% 50.8% -45.6% 71.1% 20.6% -78.3% 492.3% -17.9% 24.0%
FCF per Share 0.41
0.52
0.51
0.50
0.32
0.37
0.37
0.43
0.50
0.65
0.99
growth rate 26.8% -1.9% -2.0% -36.0% 15.6% 0.0% 16.2% 16.3% 30.0% 52.3%
Sale Purchase of Stock 60.00
114.00
111.00
85.00
growth rate 90.0% -2.6% -23.4%
FCF 704.00
1,034.00
837.00
1,010.00
353.00
596.00
1,107.00
-6.00
1,375.00
1,132.00
1,316.00
growth rate 46.9% -19.1% 20.7% -65.1% 68.8% 85.7% -100.0% 100.0% -17.7% 16.3%
Income Statement Dec '11 Dec '12 Dec '13 Dec '14 Dec '15 Dec '16 Dec '17 Dec '18 Dec '19 Dec '20 Dec '21
Sales 5,929.92
5,639.72
5,557.25
7,308.00
7,477.00
8,386.00
9,048.00
9,823.00
10,735.00
9,913.00
11,888.00
growth rate -4.9% -1.5% 31.5% 2.3% 12.2% 7.9% 8.6% 9.3% -7.7% 19.9%
Op.Income 703.31
-3,009.30
93.36
959.00
1,083.00
1,391.00
1,599.00
1,724.00
1,831.00
1,129.00
2,009.00
growth rate -100.0% 100.0% 927.2% 12.9% 28.4% 15.0% 7.8% 6.2% -38.3% 78.0%
IBT 499.48
-3,195.25
-173.49
-509.00
-650.00
177.00
932.00
1,422.00
687.00
-80.00
1,077.00
growth rate -100.0% 0.0% 0.0% 0.0% 100.0% 426.6% 52.6% -51.7% -100.0% 100.0%
Net Income 343.10
-3,164.90
-94.14
-119.00
-239.00
347.00
104.00
1,671.00
4,700.00
-82.00
1,041.00
growth rate -100.0% 0.0% 0.0% 0.0% 100.0% -70.0% 1,506.7% 181.3% -100.0% 100.0%
EPS 0.29
-2.89
-0.09
-0.09
-0.18
0.25
0.08
1.19
3.33
-0.08
0.69
growth rate -100.0% 0.0% 0.0% 0.0% 100.0% -68.0% 1,387.5% 179.8% -100.0% 100.0%
Gross Profit 3,861.21
3,812.20
3,865.88
5,092.00
5,301.00
5,939.00
6,442.00
6,993.00
7,632.00
6,793.00
8,241.00
growth rate -1.3% 1.4% 31.7% 4.1% 12.0% 8.5% 8.6% 9.1% -11.0% 21.3%
R&D 696.31
689.31
669.86
817.00
876.00
920.00
997.00
1,113.00
1,174.00
1,139.00
1,204.00
growth rate -1.0% -2.8% 22.0% 7.2% 5.0% 8.4% 11.6% 5.5% -3.0% 5.7%

Quarterly Statements

Item Name Sep '21 Dec '21 Mar '22 Jun '22 Sep '22
Earnings BIT 458.00
664.00
527.00
518.00
544.00
growth rate 45.0% -20.6% -1.7% 5.0%
Balance Sheet Sep '21 Dec '21 Mar '22 Jun '22 Sep '22
Acct.Receivable 1,669.00
1,778.00
1,866.00
1,917.00
growth rate 6.5% 5.0% 2.7%
Acct.Payable 674.00
794.00
696.00
732.00
growth rate 17.8% -12.3% 5.2%
Cur.Assets 6,229.00
6,317.00
5,065.00
5,083.00
growth rate 1.4% -19.8% 0.4%
Total Assets 31,877.00
32,229.00
32,337.00
32,189.00
growth rate 1.1% 0.3% -0.5%
Cash 1,947.00
1,925.00
325.00
276.00
growth rate -1.1% -83.1% -15.1%
Inventory 1,603.00
1,610.00
1,736.00
1,752.00
growth rate 0.4% 7.8% 0.9%
Cur.Liabilities 4,022.00
4,274.00
4,275.00
3,883.00
growth rate 6.3% 0.0% -9.2%
Liabilities 15,415.00
15,607.00
15,602.00
14,938.00
growth rate 1.3% 0.0% -4.3%
LT Debt 8,818.00
8,798.00
9,061.00
8,797.00
growth rate -0.2% 3.0% -2.9%
Equity 16,462.00
16,622.00
16,622.00
17,251.00
17,251.00
growth rate 1.0% 0.0% 3.8% 0.0%
Common Shares 17.00
17.00
17.00
17.00
growth rate 0.0% 0.0% 0.0%
Cash Flow Statement Sep '21 Dec '21 Mar '22 Jun '22 Sep '22
Capital Expenditures 107.00
266.00
121.00
105.00
growth rate 148.6% -54.5% -13.2%
Cash Dividends 14.00
13.00
14.00
14.00
growth rate -7.1% 7.7% 0.0%
Cash From OA 465.00
478.00
-58.00
307.00
growth rate 2.8% -100.0% 100.0%
Sale Purchase of Stock
growth rate
FCF 358.00
212.00
-179.00
202.00
growth rate -40.8% -100.0% 100.0%
Income Statement Sep '21 Dec '21 Mar '22 Jun '22 Sep '22
Sales 2,932.00
3,127.00
3,026.00
3,244.00
3,170.00
growth rate 6.7% -3.2% 7.2% -2.3%
Op.Income 458.00
664.00
527.00
518.00
544.00
growth rate 45.0% -20.6% -1.7% 5.0%
IBT 483.00
121.00
155.00
345.00
245.00
growth rate -75.0% 28.1% 122.6% -29.0%
Net Income 419.00
95.00
110.00
260.00
188.00
growth rate -77.3% 15.8% 136.4% -27.7%
EPS
growth rate
Gross Profit 2,018.00
2,257.00
2,104.00
2,222.00
2,217.00
growth rate 11.8% -6.8% 5.6% -0.2%
R&D 310.00
320.00
319.00
335.00
339.00
growth rate 3.2% -0.3% 5.0% 1.2%

Growth Grade & Financial Ratios

All financial ratios below are calculated based on latest annual statements available and present the most up to date snapshot of a company finances.

Growth Grade

Historical Growth Grade:

C (61.64)

YOY Growth Grade:

E (32.34)

Click on buttons above for detailed yearly growth rates.

Market Ratios

  • Dividend Yield: 0.0%

  • Beta: 0.82

    Beta of 0.8242 suggests that the asset is less volatile than the rest of the market.

  • PE: 70.51

  • EY: 1.4%

  • PEG: 1.18

    PEG Ratio of 1.18 suggests that stock is reasonably priced.

  • PEGY: 1.18

    PEGY Ratio of 1.18 suggests that stock is reasonably priced.

  • Price/BVPS: 4.73

Profitability Ratios

  • ROE: 6.2%

    Return on Equity (ROE) of 6.2% suggests that a company may not be able to fund future growth from within.

  • ROS: 16.9%

    The value of Return on Sales depends on the business and/or industry. Usually the higher ratio the better.

  • ROA: 3.3%

    Return on Assets (ROA). Low ratio usually means poor performance, or ineffective use of assets by management. High ratio usually means good performance.

  • ROI: 6.5%

    Return on Investment (ROI) of 6.5% suggests that a company may not be able to fund future growth from within.

  • ROIC: 4.0%

    Return on Invested Capital (ROIC) of 4.0% suggests that a company may not be able to fund future growth from within.

Liquidity Ratios

  • Current Ratio: 1.48

    Current Ratio of 1.48 suggests that a company may not be able to pay off bills as rapidly as it should.

  • Quick Ratio: 0.87

    Quick Ratio of 0.87 suggests that a company may not be able to pay off bills as rapidly as it should.

  • Cash Turnover: 5.82

    Turnover Of Cash Ratio of 5.82 suggests that a company may be vulnerable to creditors. As a result it may be unable to pay wages or utility bills.

  • Equity Ratio: 51.6%

    Equity Ratio of 51.6% suggests that a reasonably large percent of the company's assets financed by shareholder equity.

  • Debt/Equity: 93.9%

    Debt to Equity Ratio of 93.9% suggests that greater risk assumed by creditors, hence greater interest by them in the way the company is being managed.

  • Debt/FCF: 6.68

    Debt/FCF of 6.68 suggests that a company does not have enough cash to pay off its long term debt within three years.

Efficiency Ratios

  • Avg Collection Period: 54.59

    Average Collection Period of 54.59 days suggests that a company is doing well.

  • Inventory Turnover: 2.27

    Inventory Turnover Ratio of 2.27 suggests a large inventory, a never-out-of-stock situation, perhaps some obsolete items, or it could indicate poor liquidity and possible overstocking of items.

  • Cash Flow Ratio: 4.27

    Cash Flow Ratio of 4.27 suggests a company is doing OK, but lower inventory is generally viewed as a positive trend.

  • Profit Margin: 8.8%

Value Price

PE and EPS

Historical Current Forward
PE 64.07 70.69 15.33
EPS / Growth 0.68

Value Price & Investment Recovery Time

Read more about Stock2Own value price in Stock Market: Fundamental Analysis.

Equity Growth Rate: 15.4%

Estimates Pessimistic Moderate Optimistic My Numbers
Rate of Return 15.0%
MOS Price % 50 %
Future EPS Growth 15.4% 15.4% 15.4%
Future PE 15.33 36.71 36.71
Future EPS 2.84 2.84 2.84
Value Price
MOS %		 10.76
-77.6% 		25.75
-46.4% 		25.75
-46.4%
MOS Price 5.38 12.88 12.88
IRT 16.38 16.38 16.38

Graham Number:

NOTE: The Graham Number applies only to certain types of stocks in combination with a number of other criteria.

Read more about Graham Number in Stock Market: Fundamental Analysis.

  • Graham Number: 12.47
  • Graham MOS: -74.1%

Price Chart

The functionality you are trying to reach is available to registered users only.

Login to your account or Register Now if you are not registered yet. Registration is FREE and will take only a minute.

Risk / Reward Ratios

The functionality you are trying to reach is available to registered users only.

Login to your account or Register Now if you are not registered yet. Registration is FREE and will take only a minute.